Skip to main content
Carl J. Minniti Jr., MD, Oncology, Mickleton, NJ

Carl J.JosephMinnitiJr.MDFACP

Oncology Mickleton, NJ

The Minniti Center for Medical Oncology and Hematology, Member of Jefferson Medical Oncology Network

Dr. Minniti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Minniti's full profile

Already have an account?

Education & Training

  • Temple University Hospital-Fox Chase Cancer Center
    Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
  • Fox Chase Cancer Center
    Fox Chase Cancer CenterFellowship, Medical Oncology, 1989 - 1992
  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1986 - 1989
  • Ponce Health Sciences University School of Medicine
    Ponce Health Sciences University School of MedicineClass of 1986
  • Saint Joseph's University
    Saint Joseph's UniversityBS, Biology, 1978 - 1982

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1988 - 2025
  • PA State Medical License
    PA State Medical License 1989 - 2024
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • David King Community Clinical Scientist National Award ACCC Association of Community Cancer Centers, 2010
  • Physician of the Year New Jersey Hospice & Palliative Care Organization, 2012
  • Service to Mankind Award The Leukemia & Lymphoma Society Southern New Jersey Chapter, 2001
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Group study (E5493)  
    Wiernik PH, Li H, Weller E, Hochster HS, Horning SJ, Nazeer T, Gordon L, Haberman T, Minniti CJ Jr, Shapiro GR, Cassileth PA, Leukemia & Lymphoma, 1/1/2012
  • Phase III toxicity trial of carboplatin (Cb) plus either Docetaxel (D) or paclitaxel (P) in advanced non-small cell lung cancer (NSCLC): Final results of OPN 001  
    Langer CJ, Babb J, Minniti C, et al, Lung Cancer, 1/1/2003
  • Vinblastine and estramustine phosphate in metastatic renal cell carcinoma; A phase II trial of the Fox Chase Network  
    Haas N, Giantonio BJ, Litwin S, Minniti Jr CJ, Fox S, Yeslow G, Reilly R, Nahum K, Greenberg R, Halbherr T, Hudes GR, CA: A Cancer Journal for Clinicians, 1/1/2003
  • Join now to see all

Books/Book Chapters

Committees

  • Chair, Cancer Committee Inspira Medical Center Mullica Hill 1998 - Present
  • Chair, Tumor Board Inspira Medical Center Mullica Hill 1997 - Present

Professional Memberships

Other Languages

  • Spanish